Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: A randomized trial

Diabetes Care

Volumn 33, Issue 7, 2010, Pages 1413-1418

  Herrera, Miguel F ^a   Pantoja, Juan Pablo ^a   Velázquez Fernández, David ^a   Cabiedes, Javier ^b   Aguilar Salinas, Carlos ^a   García GarcíA, Eduardo ^a   Rivas, Alfredo ^c   Villeda, Christian ^a   Hernández Ramírez, Diego F ^a   Dávila, Andrea ^c   Zaraín, Aarón ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b Hap Map Laboratory   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ADIPONECTIN, HUMAN; AUTACOID; IL6 PROTEIN, HUMAN; LIPID;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM PERFORATION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; INTRAABDOMINAL FAT; LAPAROSCOPIC ROUX EN Y GASTRIC BYPASS; LAPAROSCOPY; MALE; METABOLIC SYNDROME X; OBESITY; OMENTECTOMY; OMENTUM; OPERATION DURATION; ORGAN WEIGHT; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL; ROUX Y ANASTOMOSIS; STOMACH BYPASS; THERAPY EFFECT; WEIGHT REDUCTION; BLOOD; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MORBID OBESITY; PILOT STUDY; PROSPECTIVE STUDY;

ACUTE-PHASE PROTEINS; ADIPONECTIN; ADULT; BLOOD GLUCOSE; C-REACTIVE PROTEIN; FEMALE; GASTRIC BYPASS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTRA-ABDOMINAL FAT; LAPAROSCOPY; LEPTIN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; OMENTUM; PILOT PROJECTS; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 77958176309     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-1833     Document Type: Article

References (23)

1. Eckel R, Grundy S, Zimmet P. The metabolic syndrome. Lancet 2005;365:1415-1428
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus and its complications provisional: report of a WHO consultation. Diabet Med 1998;15:539-553
3. Third Report of the The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
4. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-1738
5. Moringo R, Casamitjana R, Delgado S, Lacy A, Deulofeu R, Conget I, Barceló-Batllori S, Gomis R, Vidal J. Insulin resistance, inflammation and the metabolic syndrome following roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care 2007;30:1906-1908
6. Haque WA, Abhimanyu G. Adipocyte biology and adipocytokines. Clin Lab Med 2004;24:217-234
7. Vettor R, Milan G, Rossato M, Federspil G. Review article: adipocytokines and insulin resistance. Aliment Pharmacol Ther 2005;22(Suppl. 2):3-10
8. Tchernof A. Visceral adipocytes and the metabolic syndrome. Nut Rev 2007;65:S24-S29
9. Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 2005;288:E454-E461
10. Klein S, Fontanta L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004;350(25):2549-2557
11. Thörne A, Lönnqvist F, Apelman J, Hellers G, Arner P. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes 2002;26:193-199
12. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000;243:243-255
13. Lee WJ, Huang MT, Wang W, Lin CM, Chen TC, Lai IR. Effects of obesity surgery on the metabolic syndrome. Arch Surg 2004;139:1088-1092
14. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;35:2683-2693
15. Hutley L, Prins JB. Fat as an endocrine organ: relationship to the metabolic syndrome. Am J Med Sci 2005;330:280-289
16. Matsuzawa Y. Adipocytokines and metabolic syndrome. Semin Vasc Med 2005;5:34-39
17. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005;56:45-62
18. Holdstock C, Engström BE, Ohrvall M, Lind L, Sundbom M, Karlsson FA. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003;88:3177-3183
19. Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J, Rossetti L. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999;48:94-98
20. Pitombo C, Araújo E, De Souza C, Pareja J, Geloneze B, Velloso L. Amelioration of diet-induced diabetes mellitus by removal of visceral fat. J Endocrinol 2006;191:699-706
21. Kim YW, Kim JY, Lee SK. Surgical removal of visceral fat decreases plasma free fatty acid and increases insulin sensitivity on liver and peripheral tissue in monosodium glutamate (MSG)-obese rats. J Korean Med Sci 1999;14:539-545
22. Lottati M, Kolka C, Stefanovski D, Kirkman E, Bergman R. Greater omentectomy improves insulin sensitivity in nonobese dogs. Obesity 2009;17:674-680
23. Csendes A, Maluenda F, Burgos A. A prospective randomized study comparing patients with morbid obesity submitted to laparotomic gastric bypass with or without omentectomy. Obes Surg 2009;19:490-494